In order to translate nanotechnology into medical practice, magnetic nanoparticles (MNPs)
have been presented as a class of non‐invasive nanomaterials for numerous biomedical …

The promise of nucleic acid based oligonucleotides as effective genetic therapies has been
held back by their low bioavailability and poor cellular uptake to target tissues upon systemic …

Supramolecular chemistry continues to experience widespread growth, as fine-tuned
chemical structures lead to well-defined bulk materials. Previous literature described the …

Cell penetrating peptides (CPPs) can be broadly defined as relatively short synthetic, protein
derived or chimeric peptides. Their most remarkable property is their ability to cross cell …

The plasma membrane is a large barrier to systemic drug delivery into cells, and it limits the
efficacy of drug cargo. This issue has been overcome using cell-penetrating peptides …

Cell-penetrating peptides (CPPs) are delivery vectors widely used to aid the transport of
biologically active cargoes to intracellular targets. These cargoes include small interfering …

As the field of gene therapy progresses, an increasingly urgent need has arisen for efficient
and non-toxic vectors for the in vivo delivery of nucleic acids. Cell-penetrating peptides …

Modifying cell-penetrating peptides (CPPs) with fatty acids has long been used to improve
peptide-mediated nucleic acid delivery. In this study we have revisited this phenomenon …

Concerns associated with nanocarriers' therapeutic efficacy and side effects have led to the
development of strategies to advance them into targeted and responsive delivery systems …

Extracellular synthetic nucleic acids, such as siRNAs, are unable to reach their intended
targets efficiently. Therefore, delivery methods such as cell-penetrating peptides (CPP) …